Mar 14, 2024 | a&r News, Regulatory
Certain substance-based medical devices that are not yet certified under the MDR may retain their market authorization under specific conditions until 31 December 2027, or even until 31 December 2028 (see the extended transition period defined in Article 120 of...
Jan 16, 2023 | Regulatory
A lengthy French national court case on hemp flowers and leaves has concluded with a Council of State ruling, which has positive implications for the CBD industry. The Council of State determined that CBD, non-psychotropic and non-addictive, cannot be considered a...
Dec 21, 2022 | Regulatory
Good news for manufacturers of medical devices still marketed under a Medical Device Directive (MDD) certificate: On Friday 9 December, the European Commission proposed a further extension of the MDR transition period the EPSCO meeting in Brussels. The proposed...
Dec 21, 2022 | Regulatory
a&r was approved as a company engaged in research and development, and therefore received the approval for the research tax credit from the French Ministry of Higher Education, Research and Innovation. The Research Tax Credit (CIR) is a tax measure of...
Dec 21, 2022 | Regulatory
a&r was approved as a company engaged in research and development, and therefore received the approval for the research tax credit from the French Ministry of Higher Education, Research and Innovation. The Research Tax Credit (CIR) is a tax measure of...
